• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部进展期胃癌患者行D2胃切除术并完整系膜切除后的短期结局:高质量研究的系统评价和荟萃分析

Short-Term Outcomes after D2 Gastrectomy with Complete Mesogastric Excision in Patients with Locally Advanced Gastric Cancer: A Systematic Review and Meta-Analysis of High-Quality Studies.

作者信息

Granieri Stefano, Sileo Annaclara, Altomare Michele, Frassini Simone, Gjoni Elson, Germini Alessandro, Bonomi Alessandro, Akimoto Eigo, Wong Chun Lam, Cotsoglou Christian

机构信息

General Surgery Unit, ASST Brianza-Vimercate Hospital, 20871 Vimercate, Italy.

General Surgery Residency Program, University of Milan, 20122 Milan, Italy.

出版信息

Cancers (Basel). 2023 Dec 31;16(1):199. doi: 10.3390/cancers16010199.

DOI:10.3390/cancers16010199
PMID:38201626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10778561/
Abstract

Complete mesogastric excision (CME) has been advocated to allow for a more extensive retrieval of lymph nodes, as well as lowering loco-regional recurrence rates. This study aims to analyze the short-term outcomes of D2 radical gastrectomy with CME compared to standard D2 gastrectomy. A systematic review of the literature was conducted according to the Cochrane recommendations until 2 July 2023 (PROSPERO ID: CRD42023443361). The primary outcome, expressed as mean difference (MD) and 95% confidence intervals (CI), was the number of harvested lymph nodes (LNs). Meta-analyses of means and binary outcomes were developed using random effects models to assess heterogeneity. The risk of bias in included studies was assessed with the RoB 2 and ROBINS-I tools. There were 13 studies involving 2009 patients that were included, revealing a significantly higher mean number of harvested LNs in the CME group (MD: 2.55; 95% CI: 0.25-4.86; 95%; = 0.033). The CME group also experienced significantly lower intraoperative blood loss, a lower length of stay, and a shorter operative time. Three studies showed a serious risk of bias, and between-study heterogeneity was mostly moderate or high. Radical gastrectomy with CME may offer a safe and more radical lymphadenectomy, but long-term outcomes and the applicability of this technique in the West are still to be proven.

摘要

全胃系膜切除术(CME)已被提倡用于更广泛地清扫淋巴结,并降低局部区域复发率。本研究旨在分析与标准D2根治性胃切除术相比,行CME的D2根治性胃切除术的短期疗效。根据Cochrane推荐意见,截至2023年7月2日进行了一项系统的文献综述(PROSPERO编号:CRD42023443361)。主要结局指标以平均差(MD)和95%置信区间(CI)表示,为清扫淋巴结(LN)的数量。采用随机效应模型进行均值和二元结局的Meta分析,以评估异质性。使用RoB 2和ROBINS-I工具评估纳入研究的偏倚风险。纳入了13项研究,共2009例患者,结果显示CME组清扫的LN平均数量显著更高(MD:2.55;95%CI:0.25 - 4.86;P = 0.033)。CME组术中失血量也显著更低,住院时间更短,手术时间更短。三项研究显示存在严重的偏倚风险,研究间异质性大多为中度或高度。行CME的根治性胃切除术可能提供一种安全且更彻底的淋巴结清扫术,但该技术在西方的长期疗效及适用性仍有待证实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e77/10778561/90c8286f53da/cancers-16-00199-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e77/10778561/cd392536f053/cancers-16-00199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e77/10778561/fc1787fac80e/cancers-16-00199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e77/10778561/d1cb568a383c/cancers-16-00199-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e77/10778561/a85b97618f5e/cancers-16-00199-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e77/10778561/90c8286f53da/cancers-16-00199-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e77/10778561/cd392536f053/cancers-16-00199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e77/10778561/fc1787fac80e/cancers-16-00199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e77/10778561/d1cb568a383c/cancers-16-00199-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e77/10778561/a85b97618f5e/cancers-16-00199-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e77/10778561/90c8286f53da/cancers-16-00199-g005.jpg

相似文献

1
Short-Term Outcomes after D2 Gastrectomy with Complete Mesogastric Excision in Patients with Locally Advanced Gastric Cancer: A Systematic Review and Meta-Analysis of High-Quality Studies.局部进展期胃癌患者行D2胃切除术并完整系膜切除后的短期结局:高质量研究的系统评价和荟萃分析
Cancers (Basel). 2023 Dec 31;16(1):199. doi: 10.3390/cancers16010199.
2
Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial.全胃系膜切除术治疗局部进展期胃癌:一项随机临床试验的短期结果。
Cell Rep Med. 2021 Mar 16;2(3):100217. doi: 10.1016/j.xcrm.2021.100217.
3
Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.比较腹腔镜远端胃癌切除术(D2淋巴结清扫术加完整胃系膜切除术,D2+CME)与传统D2淋巴结清扫术治疗局部进展期胃腺癌的前瞻性随机对照试验:一项随机对照试验的研究方案
Trials. 2018 Aug 9;19(1):432. doi: 10.1186/s13063-018-2790-5.
4
D2 lymphadenectomy with complete mesogastrium excision vs. conventional D2 gastrectomy for advanced gastric cancer.D2 淋巴结清扫术联合完整横结肠系膜切除术与传统 D2 胃癌根治术治疗进展期胃癌的对比。
Chin Med J (Engl). 2022 May 20;135(10):1223-1230. doi: 10.1097/CM9.0000000000002023.
5
[Short-term efficacy evaluation of laparoscopic spleen-preserving splenic hilus lymphadenectomy and left epigastrium mesogastric excision for advanced proximal gastric cancer based on mesangial anatomy].基于系膜解剖的腹腔镜保留脾脏脾门淋巴结清扫联合左上腹系膜胃切除术治疗进展期近端胃癌的短期疗效评估
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Feb 25;23(2):177-182. doi: 10.3760/cma.j.issn.1671-0274.2020.02.014.
6
Short-term outcomes of D2 lymphadenectomy plus complete mesogastric excision for gastric cancer: a propensity score matching analysis.D2 淋巴结清扫加全胃系膜切除术治疗胃癌的短期疗效:倾向评分匹配分析。
Surg Endosc. 2022 Aug;36(8):5921-5929. doi: 10.1007/s00464-022-09092-2. Epub 2022 May 31.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
["See fine world" -copy experience and thinking of membrane anatomy in laparoscopic radical gastrectomy (D2+CME)].["见证美好世界" - 腹腔镜根治性胃癌切除术(D2+CME)中膜解剖的复制经验与思考]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 May 25;22(5):418-422. doi: 10.3760/cma.j.issn.1671-0274.2019.05.004.
9
Laparoscopic D2 plus complete mesogastrium excision using the "enjoyable space" approach versus conventional D2 total gastrectomy for local advanced gastric cancer: short-term outcomes.腹腔镜D2加完整胃系膜切除术采用“愉悦空间”入路与传统D2全胃切除术治疗局部进展期胃癌的短期疗效
Wideochir Inne Tech Maloinwazyjne. 2020 Mar;15(1):58-69. doi: 10.5114/wiitm.2019.85540. Epub 2019 May 29.
10
Laparoscopic vs. open distal gastrectomy for locally advanced gastric cancer: A systematic review and meta-analysis of randomized controlled trials.腹腔镜与开放远端胃癌切除术治疗局部进展期胃癌:一项随机对照试验的系统评价和荟萃分析
Front Surg. 2023 Feb 17;10:1127854. doi: 10.3389/fsurg.2023.1127854. eCollection 2023.

本文引用的文献

1
The short- and long-term effect of membrane anatomy-guided laparoscopic D2 lymphadenectomy plus regional complete mesogastrium excision for locally advanced gastric cancer.膜解剖导向腹腔镜 D2 淋巴结清扫术加区域全胃系膜切除术治疗局部进展期胃癌的近期和远期效果。
Surg Endosc. 2023 Jun;37(6):4990-5003. doi: 10.1007/s00464-023-10089-8. Epub 2023 May 8.
2
Totally laparoscopic total gastrectomy using the "enjoyable space" approach coupled with self-pulling and latter transection reconstruction versus laparoscopic-assisted total gastrectomy for upper gastric cancer: short-term outcomes.采用“愉悦空间”入路结合自牵引及后切断重建的全腹腔镜全胃切除术与腹腔镜辅助全胃切除术治疗胃上部癌的短期疗效
Wideochir Inne Tech Maloinwazyjne. 2022 Jun;17(2):352-364. doi: 10.5114/wiitm.2022.113568. Epub 2022 Feb 18.
3
Short-term outcomes of D2 lymphadenectomy plus complete mesogastric excision for gastric cancer: a propensity score matching analysis.D2 淋巴结清扫加全胃系膜切除术治疗胃癌的短期疗效:倾向评分匹配分析。
Surg Endosc. 2022 Aug;36(8):5921-5929. doi: 10.1007/s00464-022-09092-2. Epub 2022 May 31.
4
D2 lymphadenectomy with complete mesogastrium excision vs. conventional D2 gastrectomy for advanced gastric cancer.D2 淋巴结清扫术联合完整横结肠系膜切除术与传统 D2 胃癌根治术治疗进展期胃癌的对比。
Chin Med J (Engl). 2022 May 20;135(10):1223-1230. doi: 10.1097/CM9.0000000000002023.
5
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.《胃癌,第2.2022版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南》
J Natl Compr Canc Netw. 2022 Feb;20(2):167-192. doi: 10.6004/jnccn.2022.0008.
6
Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial.全胃系膜切除术治疗局部进展期胃癌:一项随机临床试验的短期结果。
Cell Rep Med. 2021 Mar 16;2(3):100217. doi: 10.1016/j.xcrm.2021.100217.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Gastric equivalent of the 'Holy Plane' to standardize the surgical concept of stomach cancer to mesogastric excision: updating Jamieson and Dobson's historic schema.胃的“神圣平面”相当于胃癌的标准系膜切除术:对 Jamieson 和 Dobson 历史分期方案的更新。
Gastric Cancer. 2021 Mar;24(2):273-282. doi: 10.1007/s10120-020-01142-9. Epub 2021 Jan 2.
9
Recurrence pattern and its predictors for advanced gastric cancer after total gastrectomy.全胃切除术后进展期胃癌的复发模式及其预测因素。
Medicine (Baltimore). 2020 Dec 18;99(51):e23795. doi: 10.1097/MD.0000000000023795.
10
Minimally invasive gastrectomy for cancer and anastomotic options.癌症的微创胃切除术和吻合选项。
J Surg Oncol. 2020 Jul;122(1):49-60. doi: 10.1002/jso.25904. Epub 2020 Mar 22.